These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 10752873)

  • 21. Disodium etidronate in the prevention of heterotopic ossification following spinal cord injury (preliminary report).
    Stover SL; Hahn HR; Miller JM
    Paraplegia; 1976 Aug; 14(2):146-56. PubMed ID: 823516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association between deep venous thrombosis and heterotopic ossification in patients with acute traumatic spinal cord injury.
    Colachis SC; Clinchot DM
    Paraplegia; 1993 Aug; 31(8):507-12. PubMed ID: 8414634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disodium etidronate: its role in preventing heterotopic ossification in severe head injury.
    Spielman G; Gennarelli TA; Rogers CR
    Arch Phys Med Rehabil; 1983 Nov; 64(11):539-42. PubMed ID: 6416224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterotopic ossification in a tetraplegic patient with prolonged fever.
    Lee JW; Jo YS; Park JS; Kim JM; Kim SK
    J Rehabil Med; 2015 Aug; 47(7):669-71. PubMed ID: 26074210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disodium etidronate in the prevention of postoperative recurrence of heterotopic ossification in spinal-cord injury patients.
    Stover SL; Niemann KM; Miller JM
    J Bone Joint Surg Am; 1976 Jul; 58(5):683-8. PubMed ID: 819446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent hypercoagulation associated with heterotopic ossification in patients with spinal cord injury long after injury has occurred.
    Perkash A; Sullivan G; Toth L; Bradleigh LH; Linder SH; Perkash I
    Paraplegia; 1993 Oct; 31(10):653-9. PubMed ID: 8259328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Etidronate therapy decreases the sensitivity of bone scanning with methylene diphosphonate labelled with technetium-99m.
    Murphy KJ; Line BR; Malfetano J
    Can Assoc Radiol J; 1997 Jun; 48(3):199-202. PubMed ID: 9193420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. False-negative triple-phase bone scans in spinal cord injury to detect clinically suspect heterotopic ossification: a case series.
    Svircev JN; Wallbom AS
    J Spinal Cord Med; 2008; 31(2):194-6. PubMed ID: 18581667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rachitic syndrome after disodium etidronate therapy in an adolescent.
    Silverman SL; Hurvitz EA; Nelson VS; Chiodo A
    Arch Phys Med Rehabil; 1994 Jan; 75(1):118-20. PubMed ID: 8291954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indomethacin and disodium etidronate for the prevention of recurrence of heterotopic ossification after surgical resection. Two case reports.
    Biering-Sørensen F; Tøndevold E
    Paraplegia; 1993 Aug; 31(8):513-5. PubMed ID: 8414635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muscle localization of heterotopic ossification following spinal cord injury.
    Ohlmeier M; Suero EM; Aach M; Meindl R; Schildhauer TA; Citak M
    Spine J; 2017 Oct; 17(10):1519-1522. PubMed ID: 28456672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of preoperative hip heterotopic ossification extent on recurrence in patients with head and spinal cord injury: a case control study.
    Genêt F; Jourdan C; Lautridou C; Chehensse C; Minooee K; Denormandie P; Schnitzler A
    PLoS One; 2011; 6(8):e23129. PubMed ID: 21853078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of immature heterotopic ossification (HO) of the hip.
    Jamil F; Subbarao JV; Banaovac K; El Masry WS; Bergman SB
    Spinal Cord; 2002 Aug; 40(8):388-95. PubMed ID: 12124665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperphosphatemia in a patient with spinal cord injury who received etidronate for the treatment of heterotopic ossification.
    Taravati S; Cinar E; Akkoc Y
    Spinal Cord Ser Cases; 2017; 3():17032. PubMed ID: 28616259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandin E2 measurements: their value in the early diagnosis of heterotopic ossification in spinal cord injury patients.
    Schurch B; Capaul M; Vallotton MB; Rossier AB
    Arch Phys Med Rehabil; 1997 Jul; 78(7):687-91. PubMed ID: 9228869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The sensitivity of ultrasound screening examination in detecting heterotopic ossification following spinal cord injury.
    Rosteius T; Suero EM; Grasmücke D; Aach M; Gisevius A; Ohlmeier M; Meindl R; Schildhauer TA; Citak M
    Spinal Cord; 2017 Jan; 55(1):71-73. PubMed ID: 27349610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-hospital outcomes following single-dose radiation therapy in the treatment of heterotopic ossification of the hip following spinal cord injury-an analysis of 444 cases.
    Müseler AC; Grasmücke D; Jansen O; Aach M; Meindl R; Schildhauer TA; Citak M
    Spinal Cord; 2017 Mar; 55(3):244-246. PubMed ID: 27431658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The echographic diagnosis of neurogenic paraosteoarthropathies in myelosis patients].
    Pistarini C; Carlevati S; Contardi A
    G Ital Med Lav; 1993; 15(5-6):159-63. PubMed ID: 7615177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pelvic MRI in spinal cord injury patients: incidence of muscle signal change and early heterotopic ossification.
    McKean D; Ather S; Gandhi A; Hubble T; Belci M; Tiberti S; Papanikitas J; Yanny S; King D; Hughes R; Meagher T; de Heredria LL
    Spinal Cord; 2021 Jun; 59(6):635-641. PubMed ID: 32873893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel mouse model of spinal cord injury-induced heterotopic ossification.
    Kang H; Dang AB; Joshi SK; Halloran B; Nissenson R; Zhang X; Li J; Kim HT; Liu X
    J Rehabil Res Dev; 2014; 51(7):1109-18. PubMed ID: 25436890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.